Antileukoproteinase antibody LS-C10072 is an unconjugated goat polyclonal antibody to human Antileukoproteinase (SLPI). Validated for ELISA, Neut and WB.
Human SLPI / Antileukoproteinase
(tested or 100% immunogen sequence identity)
Also available conjugated with Biotin
- Western blot (0.1 - 0.2 µg/ml)
- ELISA (0.5 - 1 µg/ml)
- (applications tested for the base form of this product only)
Purified, E. coli-derived, recombinant human secretory leukocyte protease inhibitor (SLPI).
Recognizes human SLPI in direct ELISA and Western Blot. ~20% cross-reactivity with mSLPI (ELISA). Antibody neutralizes SLPI biological activity.
Suitable for use in Neutralization, Direct ELISA, Western Blot. Neutralization: ~20 ng of antibody will neutralize 50% of the activity due to 1 ng of rhSLPI. Inhibits trypsin-catalyzed hydrolysis of tosyl-Gly-Pro-Lys-4-nitroanilide acetate. Recombinant human SLPI will inhibit trypsin activity at a 1:1 molar ratio of rhSLPI to active trypsin. Direct ELISA: 0.5-1.0 ug/ml. The detection limit for rhSLPI is approximately 0.03 ng/well. Western Blot: 0.1-0.2 ug/ml with the appropriate secondary reagents to detect human SLPI. The detection limit for rhSLPI is ~1 ng/lane under non-reducing and reducing conditions.
PBS, pH 7.2, 40% Glycerol
Short term: 4°C; Long term: Add glycerol (40-50%) -20°C.
For research use only.
About SLPI / Antileukoproteinase